Stephen Kraus
CIK 1362099 · last filed 2025-10-06
Stephen Kraus is a corporate insider who has filed 13 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for BHG, was dated Oct 6, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
6
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NeueHealth, Inc. (BHG) Delisted | Director | 0 | $16.35 | $0 | $0 | 5 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | Director | 16,444 | $6.75 | $111.0K | $0 | 2 | 2025-05-15 |
| Allena Pharmaceuticals, Inc. (ALNA) Delisted | Director | 0 | $0.07 | $0 | $0 | 1 | 2017-11-06 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | — | — | — | $0 | 1 | 2013-06-11 |
| VSTM | Director | 0 | $4.10 | $0 | $0 | 2 | 2012-03-08 |
| Restore Medical, Inc. (REST) Delisted | Director | — | — | — | $0 | 1 | 2008-07-16 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-06 | NeueHealth, Inc. (BHG) Delisted | Disp (D) | −16,443 | $0 | EDGAR |
| 2025-05-15 | NeueHealth, Inc. (NEUE) Delisted | Exer (M) | +10,500 | $0 | EDGAR |
| 2024-05-14 | NeueHealth, Inc. (NEUE) Delisted | Mixed | +4,755 | $0 | EDGAR |
| 2023-05-16 | NeueHealth, Inc. (BHG) Delisted | Mixed | +95,109 | $0 | EDGAR |
| 2022-10-19 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-17 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | NeueHealth, Inc. (BHG) Delisted | Conv (C) | — | $0 | EDGAR |
| 2017-11-06 | Allena Pharmaceuticals, Inc. (ALNA) Delisted | Mixed | — | $0 | EDGAR |
| 2013-06-11 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-08-14 | — | Conv (C) | — | $0 |